Compare BTDR & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTDR | TWST |
|---|---|---|
| Founded | 2021 | 2013 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.0B |
| IPO Year | 2021 | 2018 |
| Metric | BTDR | TWST |
|---|---|---|
| Price | $12.34 | $56.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | $22.70 | ★ $46.88 |
| AVG Volume (30 Days) | ★ 5.8M | 1.3M |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $72.51 | $18.91 |
| Revenue Next Year | $40.84 | $15.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $7.04 | $23.30 |
| 52 Week High | $27.80 | $66.06 |
| Indicator | BTDR | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 62.02 | 51.63 |
| Support Level | $11.96 | $41.85 |
| Resistance Level | $13.22 | $57.88 |
| Average True Range (ATR) | 0.75 | 3.49 |
| MACD | -0.08 | -0.66 |
| Stochastic Oscillator | 68.69 | 8.31 |
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.